Advertisement
BD Biosciences
BD Biosciences

Most Recent

image: Trouble at the CDC?

Trouble at the CDC?

By | March 12, 2012

Anonymous letters to The Lancet point to problems with the CDC's Center for Global Health, but the agency denies the allegations.

4 Comments

image: High Tumor Heterogeneity Confirmed

High Tumor Heterogeneity Confirmed

By | March 9, 2012

One biopsy may not provide enough information about the array of mutations in cancer to devise treatments based on a tumor’s genetic profile.

2 Comments

image: Origami Sensors

Origami Sensors

By | March 9, 2012

An inexpensive 3-D paper sensor could test for HIV and malaria.

2 Comments

image: H5N1 Insiders Speak Out

H5N1 Insiders Speak Out

By | March 6, 2012

NSABB and Congress members voice their opinions about the new developments in the H5N1 research debate.

0 Comments

image: Designer Aspirin Fights Cancer

Designer Aspirin Fights Cancer

By | March 5, 2012

Early experiments show that a hybrid form of the common pain reliever can effectively inhibit the growth of many tumor types.

0 Comments

image: Bioethicist Resigns from CellTex

Bioethicist Resigns from CellTex

By | March 1, 2012

Bioethicist Glenn McGee, founder of the American Journal of Bioethics, resigned from a controversial stem cell company.

2 Comments

image: A Whiff of TB

A Whiff of TB

By | March 1, 2012

Chemical ecologist Max Suckling at the Institute for Plant and Food Research Ltd., and summer student Rachael Sagar use Pavlovian conditioning to train bees to stick out their tongues, or proboscises, at the scent of odors produced by tuberculosis-causing bacteria.

0 Comments

image: What it Takes to Develop Better Drugs for Kids

What it Takes to Develop Better Drugs for Kids

By | March 1, 2012

Over the past 15 years, new laws and regulations in the United States and the European Union have expanded to require the inclusion of pediatric patients in clinical drug trials.  

2 Comments

Contributors

March 1, 2012

Meet some of the people featured in the March 2012 issue of The Scientist.

0 Comments

image: Are the Kids Alright?

Are the Kids Alright?

By | March 1, 2012

Two key pieces of legislation, enacted to spur drugmakers into testing pharmaceutical products in children, are up for reauthorization in the US Congress this October. Have they done their jobs?

6 Comments

Advertisement
EMD Millipore
EMD Millipore

Popular Now

  1. Antibody Alternatives
    Features Antibody Alternatives

    Nucleic acid aptamers and protein scaffolds could change the way researchers study biological processes and treat disease.

  2. The Mycobiome
    Features The Mycobiome

    The largely overlooked resident fungal community plays a critical role in human health and disease.

  3. Circadian Clock and Aging
    Daily News Circadian Clock and Aging

    Whether a critical circadian clock gene is deleted before or after birth impacts the observed aging-related effects in mice.

  4. Biologist Resigns Amid Sexual Misconduct Probe
Advertisement
PDA
PDA
Advertisement
Life Technologies